\-\ Texto\\:\\ \ \(0\)\
\-\ hgb\\:\\ 7\\.7\\ g\\/dl\ \(0\)\
\-\ hct\\:\\ 21\\.7\\ \\%\ \(0\)\
\-\ platelets\\ 106\\,000\ \(0\)\
\-\ pt\\ 15\\.4\\ sec\\ \\(12\\.8\\-15\\.0\\)\ \(0\)\
\-\ inr\\ 1\\.1\\ \\(2\\.0\\-4\\.5\\)\ \(0\)\
\-\ patient\\ had\\ a\\ recurrent\\ bleed\\ 4\\ days\\ later\\ by\\ a\\ nuclear\\ medicine\\ gi\\ bleed\\ study\\.\\ \\ subsequent\\ angiogram\\ demonstrated\\ diffuse\\ hyperemia\\ of\\ the\\ duodenum\\ with\\ extravasation\\ of\\ contrast\\ into\\ a\\ collection\\ of\\ contrast\\ into\\ an\\ ulcer\\ crater\\ without\\ a\\ definite\\ arterial\\ feeding\\ vessel\\.\ \(0\)\
\-\ selected\\ angiogram\\ of\\ the\\ gastroduodenal\\ artery\\ demonstrates\\ focal\\ extravasation\\ off\\ of\\ the\\ branch\\ of\\ the\\ posterior\\ superior\\ pancreaticoduodenal\\ artery\\ at\\ the\\ junction\\ of\\ the\\ second\\ and\\ third\\ portions\\ of\\ the\\ duodenum\\.\ \(0\)\
\-\ post\\-embolization\\ angiogram\\ demonstrates\\ no\\ active\\ extravasation\\.\ \(0\)\
\-\ gastrointestinal\\ bleeding\ \(5\)\
\-\ n\\/a\ \(127\)\
\-\ 63\\ year\\ old\\ patient\\ nearing\\ renal\\ failure\\ with\\ fulminant\\ liver\\ failure\\ dueto\\ augmentin\\,\\ who\\ presents\\ with\\ duodenal\\ bleed\\ status\\ post\\ upper\\ endoscopyand\\ multiple\\ attempts\\ at\\ injection\\ and\\ cautery\\ of\\ the\\ bleed\\,\\ now\\ with\\ recurrent\\ hematemesis\\.\ \(0\)\
\-\ in\\ a\\ patient\\ with\\ active\\ gastrointestinal\\ hemorrhage\\,\\ the\\ source\\ can\\ be\\ localized\\ and\\ treated\\ through\\ embolization\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ bleed\\:\\ 0\\.357127226478591\ \(0\)\
\-\ extravasation\\:\\ 0\\.2855680418421373\ \(0\)\
\-\ angiogram\\:\\ 0\\.23480535970888644\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.1718625513131544\ \(0\)\
\-\ duodenum\\:\\ 0\\.17140317654962509\ \(0\)\
\-\ the\\:\\ 0\\.15646676363949463\ \(0\)\
\-\ of\\:\\ 0\\.1534551012258067\ \(0\)\
\-\ embolization\\:\\ 0\\.15186799798245615\ \(0\)\
\-\ recurrent\\:\\ 0\\.13972339846467619\ \(0\)\
\-\ nearing\\:\\ 0\\.13933666310888249\ \(0\)\
\-\ dueto\\:\\ 0\\.13933666310888249\ \(0\)\
\-\ endoscopyand\\:\\ 0\\.13933666310888249\ \(0\)\
\-\ cautery\\:\\ 0\\.13933666310888249\ \(0\)\
\-\ failure\\:\\ 0\\.13229874695978117\ \(0\)\
\-\ active\\:\\ 0\\.12939875156919925\ \(0\)\
\-\ crater\\:\\ 0\\.12534130897495013\ \(0\)\
\-\ pancreaticoduodenal\\:\\ 0\\.12534130897495013\ \(0\)\
\-\ fulminant\\:\\ 0\\.12534130897495013\ \(0\)\
\-\ augmentin\\:\\ 0\\.11816250970665094\ \(0\)\
\-\ gastroduodenal\\:\\ 0\\.11475423227383437\ \(0\)\
\-\ hematemesis\\:\\ 0\\.11329847192122011\ \(0\)\
\-\ artery\\:\\ 0\\.10822459816696771\ \(0\)\
\-\ sec\\:\\ 0\\.10416715557271859\ \(0\)\
\-\ attempts\\:\\ 0\\.10342193835939238\ \(0\)\
\-\ hyperemia\\:\\ 0\\.10203244241897338\ \(0\)\
\-\ platelets\\:\\ 0\\.09849192240201993\ \(0\)\
\-\ post\\:\\ 0\\.0948182669121434\ \(0\)\
\-\ selected\\:\\ 0\\.09358007887160281\ \(0\)\
\-\ inr\\:\\ 0\\.09320292580689005\ \(0\)\
\-\ into\\:\\ 0\\.09263150528856853\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0875443341570123\ \(0\)\
\-\ ulcer\\:\\ 0\\.08640127960330363\ \(0\)\
\-\ definite\\:\\ 0\\.08570158827481254\ \(0\)\
\-\ branch\\:\\ 0\\.08547530379448877\ \(0\)\
\-\ duodenal\\:\\ 0\\.08547530379448877\ \(0\)\
\-\ with\\:\\ 0\\.08530377256234599\ \(0\)\
\-\ patient\\:\\ 0\\.08501510763528816\ \(0\)\
\-\ contrast\\:\\ 0\\.08466744669139015\ \(0\)\
\-\ hgb\\:\\ 0\\.08460227057959667\ \(0\)\
\-\ 63\\:\\ 0\\.08418378075608308\ \(0\)\
\-\ source\\:\\ 0\\.08299300217048705\ \(0\)\
\-\ portions\\:\\ 0\\.08280326155588968\ \(0\)\
\-\ hct\\:\\ 0\\.08261584910577428\ \(0\)\
\-\ nuclear\\:\\ 0\\.0824307083776909\ \(0\)\
\-\ feeding\\:\\ 0\\.08171180283849279\ \(0\)\
\-\ localized\\:\\ 0\\.07826845323629547\ \(0\)\
\-\ medicine\\:\\ 0\\.07679995930807568\ \(0\)\
\-\ vessel\\:\\ 0\\.07642280624336291\ \(0\)\
\-\ injection\\:\\ 0\\.07581420290218786\ \(0\)\
\-\ gi\\:\\ 0\\.07318937530104369\ \(0\)\
\-\ off\\:\\ 0\\.07279262772042461\ \(0\)\
\-\ arterial\\:\\ 0\\.0717518961272177\ \(0\)\
\-\ bleeding\\:\\ 0\\.07121276051972784\ \(0\)\
\-\ collection\\:\\ 0\\.0703544491595217\ \(0\)\
\-\ junction\\:\\ 0\\.06978109786822713\ \(0\)\
\-\ third\\:\\ 0\\.0663406986085258\ \(0\)\
\-\ subsequent\\:\\ 0\\.0659604153208173\ \(0\)\
\-\ at\\:\\ 0\\.06581870822366609\ \(0\)\
\-\ second\\:\\ 0\\.06522712620107209\ \(0\)\
\-\ pt\\:\\ 0\\.06270311693992797\ \(0\)\
\-\ later\\:\\ 0\\.062353126303131334\ \(0\)\
\-\ status\\:\\ 0\\.06080328957622096\ \(0\)\
\-\ liver\\:\\ 0\\.06010493145796546\ \(0\)\
\-\ now\\:\\ 0\\.05980916160363729\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.05833439201016963\ \(0\)\
\-\ study\\:\\ 0\\.05810810752984586\ \(0\)\
\-\ superior\\:\\ 0\\.05664554213231876\ \(0\)\
\-\ days\\:\\ 0\\.05515580195911769\ \(0\)\
\-\ diffuse\\:\\ 0\\.05464004949995631\ \(0\)\
\-\ renal\\:\\ 0\\.05425707668929612\ \(0\)\
\-\ treated\\:\\ 0\\.05425707668929612\ \(0\)\
\-\ and\\:\\ 0\\.05401181251469357\ \(0\)\
\-\ demonstrated\\:\\ 0\\.05354653355000808\ \(0\)\
\-\ focal\\:\\ 0\\.052116040238812195\ \(0\)\
\-\ through\\:\\ 0\\.051865231269055144\ \(0\)\
\-\ who\\:\\ 0\\.04928498378229901\ \(0\)\
\-\ upper\\:\\ 0\\.046559861633252146\ \(0\)\
\-\ without\\:\\ 0\\.04595675191622516\ \(0\)\
\-\ can\\:\\ 0\\.04572202180502311\ \(0\)\
\-\ posterior\\:\\ 0\\.045054647833635865\ \(0\)\
\-\ had\\:\\ 0\\.04341038031461872\ \(0\)\
\-\ multiple\\:\\ 0\\.0426162081777996\ \(0\)\
\-\ presents\\:\\ 0\\.041913072372824635\ \(0\)\
\-\ by\\:\\ 0\\.03699960818103891\ \(0\)\
\-\ be\\:\\ 0\\.03534435231947057\ \(0\)\
\-\ an\\:\\ 0\\.03331746030311484\ \(0\)\
\-\ no\\:\\ 0\\.028333038929714487\ \(0\)\
\-\ year\\:\\ 0\\.02685113868402384\ \(0\)\
\-\ old\\:\\ 0\\.02578638788898228\ \(0\)\
\-\ in\\:\\ 0\\.021674622360495187\ \(0\)\
